Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Capital Leases (2016 - 2018)

Surgery Partners' Capital Leases history spans 5 years, with the latest figure at $25.4 million for Q4 2018.

  • For Q4 2018, Capital Leases changed N/A year-over-year to $25.4 million; the TTM value through Dec 2018 reached $25.4 million, changed N/A, while the annual FY2018 figure was $25.4 million, N/A changed from the prior year.
  • Capital Leases for Q4 2018 was $25.4 million at Surgery Partners, up from $24.8 million in the prior quarter.
  • Across five years, Capital Leases topped out at $52.7 million in Q4 2016 and bottomed at $10.3 million in Q3 2015.
  • The 5-year median for Capital Leases is $14.8 million (2017), against an average of $19.6 million.
  • The largest annual shift saw Capital Leases rose 5.22% in 2015 before it surged 365.71% in 2016.
  • A 5-year view of Capital Leases shows it stood at $10.8 million in 2014, then grew by 5.22% to $11.3 million in 2015, then soared by 365.71% to $52.7 million in 2016, then plummeted by 71.94% to $14.8 million in 2017, then soared by 71.6% to $25.4 million in 2018.
  • Per Business Quant, the three most recent readings for SGRY's Capital Leases are $25.4 million (Q4 2018), $24.8 million (Q3 2018), and $25.4 million (Q2 2018).